Cardiogenic Shock in Patients with Advanced Chronic Heart Failure

Cesar Y Guerrero-Miranda1, Shelley A Hall1

  • 1BAYLOR SCOTT & WHITE RESEARCH INSTITUTE, DALLAS, TEXAS; BAYLOR UNIVERSITY MEDICAL CENTER, DALLAS, TEXAS; TEXAS A&M HEALTH SCIENCE CENTER, DALLAS, TEXAS.

Insights

Managing cardiogenic shock (CS) in advanced heart failure (HF) presents unique challenges. Early multidisciplinary assessment is crucial for timely intervention and advanced therapy candidacy in these complex patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Patients with end-stage heart failure (HF) refractory to medical therapy present distinct challenges compared to those with cardiogenic shock (CS) from myocardial infarction.
  • Progression to refractory CS in advanced HF is linked to poor outcomes due to recognition, intervention, and salvage option difficulties.

Purpose of the Study:

  • To review the definition, phenotypes, and classification of CS in advanced HF patients.
  • To discuss the role of temporary mechanical circulatory support and the CS team in managing these complex cases.

Main Methods:

  • This review synthesizes current literature on CS in advanced HF.
  • Key aspects discussed include CS heterogeneity, diagnostic challenges, and treatment escalation strategies.

Main Results:

  • CS in advanced HF is heterogeneous with varied etiologies, onset, hemodynamics, and end-organ effects.
  • A universal definition for CS in this population is lacking, complicating management.
  • Blunted hemodynamic response is common due to prolonged compensatory mechanisms.

Conclusions:

  • Advanced HF patients in CS require a multidisciplinary team approach for timely assessment and escalation of care.
  • Evaluating candidacy for temporary mechanical circulatory support and advanced therapies is critical.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
343
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
244
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
161
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
609